Sisi Xiao Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2023	Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells.
1/2023	miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions.
1/2020	miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling.
11/2019	Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sisi Xiao Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 01/2020
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2019
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2020
1	Colonic Neoplasms (Colon Cancer) 04/2022

Drug/Important Bio-Agent (IBA)

2	JNK Mitogen-Activated Protein KinasesIBA 01/2023 - 04/2022
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 04/2022
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	regorafenibIBA 01/2023
1	NADPH Oxidase 5IBA 01/2023
1	Oxygen (Dioxygen)IBA 04/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022
1	artenimol (dihydroartemisinin)IBA 04/2022
1	OSM-LIF ReceptorsIBA 01/2020
1	cynaropicrinIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	thiazolyl blueIBA 11/2019

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2023